comprehensive -WSS

comprehensive

author：comprehensive 2025-09-01 15:14:56 - browse：376

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

WSS

Crinetics acromegaly drug succeeds in late

Drug for rare kidney disease narrowly misses mark in clinical trial

CommonSpirit Health keeps growing, even as it loses money

ALS advocates say criticism of new drugs misses bigger picture

How generative AI is inspiring dreams of a health data revolution

The 10 drugs up first for Medicare price negotiation

hotspot

comprehensive

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Intarcia’s device

After affirmative action ruling, medical educators look to 'holistic review'

How to protect patients from sexual assault

The cancer drug shortage isn’t new — and neither are the solutions

Readout LOUD podcast: possible new ALS drug, artificial wombs

Jerome Adams on the need for new antivirals for Covid

Illumina names Agilent executive as new CEO

Activists slam private health insurers over coverage restrictions

What drug price negotiations mean for Medicare Part D

hotspot

Hearing on Medicare drug price negotiation gets unusually heated

Humana sues Biden admin over Medicare Advantage audit rule

Ethical issues complicate the benefits of medical crowdfunding

Microbiome research is starting to find links to chronic diseases

Intarcia’s device

What drug price negotiations mean for Medicare Part D

focus

focus

hotspot

focus